If you are wondering whether Moderna's share price really reflects what the business is worth today, you are not alone. That ...

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second ...

Explore how Moderna makes money through its mRNA vaccines, government contracts, and partnerships, and how products like its COVID-19 vaccine drive revenue.

Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.

On March 3, 2026, Moderna entered into a settlement agreement with Arbutus Biopharma and Genevant Sciences to resolve all worldwide patent litigation related to Spikevax, mRESVIA and its broader ...

The Food and Drug Administration’s head of vaccines and biotechnology drugs, Dr. Vinay Prasad, is leaving the agency as of ...

The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson ...

Dr. Vinay Prasad, a polarizing figure at the Food and Drug Administration who oversaw vaccines, is leaving the agency at the end of April, according to a Health and Human Services spokesperson.

Dr. Vinay Prasad, the FDA's vaccine chief, is leaving the agency for the second time in less than a year, following ...

Dr Vinay Prasad is a former epidemiology professor at the University of California at San Francisco. Prasad joined the FDA in ...

Investors are bracing for a pivotal week for BioNTech SE, as the biotech firm prepares to release its full-year 2025 and fourth-quarter results. The upcoming re ...